The polycystic ovary syndrome (PCOS) is the disease featured by elevated levels of
androgens, ovulatory dysfunction, and morphological abnormalities. At reproductive stage of …

Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …

Polycystic ovary syndrome (PCOS) is the main cause of female infertility worldwide and
corresponds with a high degree of comorbidities and economic burden. How PCOS is …

BACKGROUND The great majority of studies performed so far concerning women
diagnosed with polycystic ovary syndrome (PCOS) have focused on diagnosis, menstrual …

Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as
reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected …

Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy among women
during reproductive age. PCOS is characterised by hyperandrogenaemia …

OBJECTIVE: To perform a review and metaanalysis of the studies evaluating the status of
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …

Accumulating evidence suggests that insults occurring during the perinatal period alter the
developmental trajectory of the fetus/offspring leading to long-term detrimental outcomes …

Myo-inositol (MI) and D-chiro-inositol (DCI) are insulin second messengers, and MI is
involved in follicular gonadotropin pathways which orchestrate ovulation. The tissue-specific …

In the ovary, Anti-Müllerian hormone (AMH) is produced by the granulosa cells of early
developing follicles and inhibits the transition from the primordial to the primary follicular …